Most of that spending — more than $34 billion — was from disproportionate share hospitals. Health center programs bought more than $2 billion worth of 340B drugs, children’s hospitals about $1.3 billion and critical access hospitals nearly $621 million.
“For 2021, discounted purchases under the 340B program reached a record $43.9 billion — an astonishing $5.9 billion (+15.6 percent) higher than its 2020 counterpart,” according to the Drug Channels Institute.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
